Change to The Company’s Board of Directors

TORONTO, June 13, 2019 (GLOBE NEWSWIRE) -- Fintech Select Ltd. (“Fintech Select” or the “Company”) (TSX-V: FTEC) reports that it has accepted the resignation of Mr. Andre Itwaru from the Company's board of directors as of June 10, 2019 for personal reasons. Mr. Itwaru had served as Chair and as a director of the Company since May 2017.

The Company has appointed Mr. Mujir Muneeruddin as a new director and will start the process of filing his application to the TSX-V for approval. The Company is actively seeking additional directors and may make one or more appointments in the future.

“We thank Mr. Itwaru for his years of service and we wish him all the best in his future endeavours,” stated Mohammad Abuleil, CEO of the Company.

FOR FURTHER INFORMATION PLEASE CONTACT:

Mohammad Abuleil, President & CEO orShelley Alliet @ - [email protected] 519-351-8647

About Fintech Select Ltd.

Fintech Select is a provider of robust and disruptive Pre-Paid Card programs and mobile banking solutions. Fintech Select has enabled these core assets which operate through separate divisions to work together harmoniously to create a new and ubiquitous environment for consumers and businesses alike. Fintech select also operates an international call centre that provides fulfillment and customer service support to customers across all three platforms mentioned. Our mission is to provide customers with choice, convenience and cost-effective ways to facilitate traditional and crypto financial transactions.

Follow us on:https://www.facebook.com/FintechSelecthttps://twitter.com/fintech_select https://www.instagram.com/fintechselecthttps://www.linkedin.com/company/fintechselect/

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

You May Also Be Interested In

• Entera Bio names Riccardo Camisasca as chief medical officer
• InterContinental Hotels Group PLC Announces Transaction in Own Shares - August 19
• Infex Therapeutics to present new RESP-X Phase IIa data in late-breaking session at ERS Congress 2026